| Serum Osm | Category | Causes |
|---|---|---|
| < 275 (low) | Hypotonic (true hyponatremia) | Most cases. Proceed to Step 2. |
| 275โ295 (normal) | Isotonic (pseudohyponatremia) | Hyperlipidemia, hyperproteinemia (multiple myeloma). Lab artifact -true Na is normal. Check lipid panel + protein. |
| > 295 (high) | Hypertonic (translocational) | Hyperglycemia (#1 -correct Na for glucose: add 1.6 mEq/L Na for every 100 mg/dL glucose above 100), mannitol, IV contrast. |
| Volume Status | Urine Na | Causes | Treatment |
|---|---|---|---|
| Hypovolemic (dry mucous membranes, orthostasis, tachycardia, skin tenting) | < 20: extrarenal losses (GI: vomiting, diarrhea; 3rd spacing: burns, pancreatitis) > 20: renal losses (diuretics, adrenal insufficiency, cerebral salt wasting) | GI losses, diuretics, adrenal crisis, burns | Volume resuscitation with NS. Na will correct as volume is restored. Watch for overcorrection -once ADH stimulus (hypovolemia) is removed, kidneys dump free water rapidly. |
| Euvolemic (no edema, no orthostasis -hardest to assess) | > 40 (inappropriately concentrated urine) | SIADH (#1), hypothyroidism, adrenal insufficiency, psychogenic polydipsia (Uosm < 100), beer potomania, tea-and-toast | Fluid restriction (SIADH). Treat underlying cause. See SIADH topic for details. |
| Hypervolemic (edema, JVD, ascites, anasarca) | < 20: CHF, cirrhosis, nephrotic syndrome (effective hypovolemia โ ADH release โ water retention) > 20: CKD/ESKD (kidneys can't excrete water) | HF, cirrhosis, nephrotic, CKD | Fluid restriction + treat underlying disease. Diuretics for HF/cirrhosis. Dialysis if ESKD. |
| Scenario | Max Correction Rate | Treatment |
|---|---|---|
| Chronic (> 48h or unknown duration) | โค 8 mEq/L in 24h (some guidelines use โค 10). High-risk for ODS: โค 6 mEq/L in 24h. | Fluid restriction (SIADH), NS (hypovolemic), treat underlying cause. Check Na q4โ6h. |
| Acute (< 48h, known onset) | Can correct faster -brain hasn't adapted. Still aim for โค 10โ12 mEq/L in 24h. | More aggressive treatment acceptable. Still monitor closely. |
| Symptomatic (seizures, coma, severe AMS) | Immediate goal: raise Na by 4โ6 mEq/L in first 6h to stop symptoms. Then โค 8 total in 24h. | 3% hypertonic saline 100โ150 mL IV bolus over 10โ20 min. SALSA, 2021 May repeat ร 2. ICU. Check Na q2h. |
Patient: 68F with SCLC, found lethargic, Naโบ 118 mEq/L.
Step 1 -Is this real? Serum osm: 248 (< 280 = true hypoosmolar hyponatremia). Not pseudohyponatremia.
Step 2 -Assess volume status:
Diagnosis: SIADH from SCLC (paraneoplastic ADH secretion)
Step 3 -Treatment:
Patient: 48M heavy beer drinker (12+ beers/day), found confused. Naโบ 108 mEq/L. No edema. Uosm 58 (maximally dilute).
Diagnosis: Beer potomania, massive free water intake with minimal solute intake โ kidneys cannot excrete the water load despite maximally dilute urine.
Treatment:
โ ๏ธ DANGER: These patients auto-correct too fast once admitted and beer is stopped. The kidneys suddenly have enough solute to excrete free water โ Na shoots up.
Key lesson: Beer potomania corrects itself dangerously fast when you admit the patient and stop beer. DDAVP rescue may be needed to SLOW correction.
Patient: 72F started on sertraline 3 weeks ago, presents with nausea and confusion. Naโบ 122 mEq/L. Euvolemic.
Labs: Uosm 580 (inappropriately concentrated). Urine Na 65. TSH and cortisol normal.
Diagnosis: Classic SIADH from SSRI.
Treatment:
Key lesson: Always check the med list for SIADH causes. SSRIs are the #1 medication cause. Fluid restriction is first-line, not hypertonic saline.
| Test | Rationale | Key Values / Interpretation |
|---|---|---|
| Serum osmolality | First step -classifies the hyponatremia. | < 275 = hypotonic (true hyponatremia -proceed to step 2). 275-295 = isotonic (pseudohyponatremia -check lipids, protein). > 295 = hypertonic (hyperglycemia -correct Na: add 1.6 mEq/L per 100 mg/dL glucose above 100). |
| Urine osmolality | Distinguishes ADH-mediated from water overload. | < 100 mOsm/kg = kidneys appropriately diluting (polydipsia, beer potomania, tea-and-toast). > 100 = ADH-mediated (inappropriate concentration โ SIADH, hypovolemia, hypervolemia). |
| Urine sodium | Differentiates renal from extrarenal sodium losses in hypovolemic states; confirms SIADH in euvolemic. | UNa < 20 = extrarenal losses (GI, third-spacing) or effective hypovolemia (CHF, cirrhosis). UNa > 40 in euvolemic state = SIADH. UNa > 20 in hypovolemic = renal losses (diuretics, adrenal insufficiency). |
| Volume status (clinical) | Essential physical exam -guides entire differential and treatment. | Hypovolemic (orthostasis, dry mucous membranes, tachycardia) โ NS. Euvolemic โ SIADH workup. Hypervolemic (edema, JVD, ascites) โ CHF/cirrhosis/nephrotic. |
| TSH | Hypothyroidism is a reversible cause -must exclude before diagnosing SIADH. | Severe hypothyroidism โ decreased free water clearance โ hyponatremia. Treat thyroid disease first. |
| AM cortisol | Adrenal insufficiency mimics SIADH (euvolemic, high UNa). Must exclude before SIADH diagnosis. | AM cortisol < 3 = adrenal insufficiency likely. 3-15 = indeterminate โ ACTH stimulation test. > 15 = AI unlikely. |
| Serum glucose | Correct Na for hyperglycemia (translocational hyponatremia). | Corrected Na = measured Na + 1.6 ร [(glucose - 100) / 100]. If corrected Na is normal โ not true hyponatremia. |
| Drug | Dose | Route | Indication | Key Notes |
|---|---|---|---|---|
| 3% Hypertonic saline | 100-150 mL IV bolus over 10-20 min. May repeat ร 2 (max 3 boluses). | IV | Severe symptomatic hyponatremia (seizures, coma, severe AMS) | ICU setting. Goal: raise Na by 4-6 mEq/L in first 6h to stop symptoms. Check Na q2h. Rapid intermittent bolus is as effective and safer than continuous infusion SALSA, 2021. |
| Fluid restriction | 1-1.5 L/day (all PO and IV fluids combined) | - | SIADH (first-line), hypervolemic hyponatremia (HF, cirrhosis) | Effective if urine osmolality is not extremely high. Poor compliance limits effectiveness. Calculate free water clearance to predict response. |
| NaCl tablets (salt tabs) | 1-3 g PO TID | PO | Chronic SIADH (with or without loop diuretic) | Often combined with furosemide 20 mg daily -the diuretic promotes free water excretion while salt tabs replenish sodium. Effective outpatient strategy. |
| Furosemide | 20-40 mg PO daily | PO | Combined with salt tabs for chronic SIADH | Impairs urinary concentration โ promotes electrolyte-free water excretion. Only effective when combined with adequate sodium intake (salt tabs). |
| Tolvaptan (Samsca) | 15 mg PO daily (may increase to 30-60 mg) | PO | Refractory SIADH or hypervolemic hyponatremia not responding to fluid restriction | V2 receptor antagonist ("vaptan") -blocks ADH at collecting duct โ aquaresis (free water loss). Must initiate inpatient. Check Na q6h for first 24h. Hepatotoxicity risk -do not use > 30 days. Do NOT use in hypovolemic hyponatremia. |
| Demeclocycline | 300-600 mg PO BID | PO | Alternative for chronic SIADH (if tolvaptan not available/tolerated) | Tetracycline that induces nephrogenic DI. Slow onset (3-5 days). Nephrotoxic -avoid in liver disease. Largely replaced by tolvaptan. |
| DDAVP (desmopressin) | 2 mcg IV q8h | IV | ODS rescue -given when Na is overcorrecting too rapidly | Clamps urine output โ stops further Na correction. Combine with D5W (3-6 mL/kg/hr) to actively re-lower Na. Target: bring correction rate back to โค 8 mEq/L in 24h. |
| D5W (5% dextrose) | 3-6 mL/kg/hr | IV | ODS rescue -free water to re-lower sodium if overcorrecting | Used with DDAVP. The dextrose is metabolized, leaving free water. Start immediately if Na rising > 8-10 mEq/L in 24h. |
Patient: 72 y/o F on sertraline x3 weeks, presents with confusion. Naโบ 112 (was 128 two weeks ago).
Key findings: Serum osm 238, urine osm 480, UNa 52, euvolemic. TSH and cortisol normal. SIADH from sertraline.
Management:
Teaching point: When the SIADH stimulus is removed, ADH drops and free water is excreted rapidly, causing overcorrection. ODS is devastating and irreversible. High-risk patients need proactive DDAVP clamping.
Patient: 55 y/o M with SCLC, found seizing at home. Naโบ 104, obtunded.
Key findings: Serum osm 218, urine osm 640, UNa 68, GCS 8. Euvolemic. Ectopic ADH from SCLC.
Management:
Teaching point: Seizures from hyponatremia require emergent 3% NaCl, the one scenario where rapid correction is indicated. Target only enough rise to stop symptoms, then strictly limit total correction.
Patient: 48 y/o M, chronic alcohol use, Naโบ 118. Drinks 12+ beers daily, minimal food intake.
Key findings: Serum osm 248, urine osm 52 (maximally dilute, ADH suppressed), UNa 8. Malnourished.
Management:
Teaching point: Urine osm < 100 rules out SIADH. Beer potomania corrects rapidly when normal diet resumes, proactive DDAVP is essential to prevent ODS. SALT-1/2, 2006 showed tolvaptan is effective for SIADH but is NOT appropriate for low-solute states.
| Parameter | Frequency | Target / Action |
|---|---|---|
| Serum sodium | q2h if on hypertonic saline; q4-6h during active correction; q6-8h once stable | Max correction โค 8 mEq/L in any 24h period (โค 6 in high-risk: alcoholism, malnutrition, hypokalemia, liver disease, Na < 105). If overcorrecting โ DDAVP + D5W rescue immediately. |
| Serum osmolality | At baseline, then q12-24h during correction | Should rise proportionally with Na. Guides assessment of correction adequacy. |
| Urine output | q1-2h during active treatment | Sudden brisk water diuresis (> 200 mL/hr of dilute urine) = danger sign for overcorrection. This happens when ADH stimulus is removed (e.g., volume resuscitation in hypovolemic hyponatremia). Start DDAVP preemptively if UOP surges. |
| Neurological status | q2-4h during active correction | Improving: resolution of confusion, seizures, lethargy = adequate correction. New dysarthria, dysphagia, quadriparesis 2-6 days after correction = ODS -MRI brain, neurology consult. |
| Potassium | With each Na check | Kโบ correction counts toward Na correction (Kโบ enters cells, Naโบ comes out). If repleting Kโบ aggressively, account for this in your correction rate calculation. |
| I&Os | Strict q1h during active treatment | Track all free water intake (IV and PO). Ensure fluid restriction is enforced if indicated. Document urine osmolality if available (Uosm < 200 on tolvaptan = expected). |